Skip to main content
Discover Hidden USA
  • News
  • Health
  • Technology
  • Business
  • Entertainment
  • Sports
  • World
Menu
  • News
  • Health
  • Technology
  • Business
  • Entertainment
  • Sports
  • World
Some patients experience mental health backlash from GLP-1 medications

Some patients experience mental health backlash from GLP-1 medications

February 3, 2026 discoverhiddenusacom Health

The use of medications like Wegovy and Zepbound, known as GLP-1s, has more than doubled in the United States since 2024. While these drugs offer significant health benefits, doctors at Brigham and Women’s Hospital are observing a less-discussed consequence: the mental health challenges some patients face—not from the medications themselves, but from societal reactions to their weight loss.

A Life Transformed

For Meredith Chambers, a patient utilizing GLP-1 medications, the impact has been profound. She reports losing 120 pounds after a lifetime of struggling with her weight, describing it as “probably the biggest thing that’s happened in my life for me.” Chambers recounts a history of repeated attempts at weight loss, stating, “Up, down, gained the weight, lost the weight, gained the weight, lost the weight.”

The Sting of “Well-Intended” Comments

Despite her success, Chambers experienced emotional difficulties stemming from comments made by others. She recalls being asked, “’Are you sick?’” and hearing suggestions that she simply “eat right” or “get off the medicine.” She acknowledges that these comments weren’t intentionally malicious, but notes the underlying message: “When people say, ‘Wow, you look so good now,’ the intent is so nice and kind, right? But to me, I hear ‘you didn’t look good before.'”

Did You Know? GLP-1 medications can help patients lose between 16% and 22% of their body weight.

The Weight of Stigma

Dr. Caroline Apovian, co-director of the Center for Weight Management at Brigham and Women’s Hospital, emphasizes that the challenges patients face are rooted in societal stigma surrounding obesity. She explains that unlike conditions like hypertension or diabetes, obesity is visibly apparent, leading to judgment. “You can’t really see if you have hypertension, high blood pressure or if you have diabetes. That’s why the judgment comes out because you can see it,” she stated.

Dr. Apovian also notes the positive impacts of these medications, including a decreased risk of heart attack and stroke, alleviation of sleep apnea and reduced joint pain. However, she fears that the stigma surrounding weight loss could deter individuals who need these drugs from seeking help. She cautions against telling someone to “control yourself” or questioning their dietary choices, describing this as “the stigma underlying everything.”

Expert Insight: The experience of patients like Meredith Chambers highlights the complex interplay between physical health, mental wellbeing, and societal perceptions. Addressing the stigma surrounding obesity is crucial to ensuring individuals feel supported in pursuing effective treatments.

A Plea for Kindness

Meredith Chambers urges people to be mindful of their words. “Just be careful of your words because, really, it can be devastating for the person hearing them,” she advises. “People always have their own thoughts. But just keep those in and just be kind.”

Frequently Asked Questions

What are GLP-1 medications?

GLP-1 medications, such as Wegovy and Zepbound, are drugs used for weight loss.

What side effects are doctors observing with these medications?

Doctors are observing mental health challenges for some patients, but these are not caused by the drugs themselves, rather by reactions from others to their weight loss.

What is the main concern Dr. Apovian expresses?

Dr. Apovian worries that the stigma surrounding obesity will prevent people who need these drugs from seeking help.

As GLP-1 medications become increasingly prevalent, how can we foster a more supportive and understanding environment for individuals undergoing weight loss journeys?

apovian, Boston, Challenge, chamber, doctors, drug, glp-1, glp-1 medication, Health, Massachusetts, medication, mental health backlash, meredith chambers, obesity, patient, patients, people, pound, stigma, weight, weight loss, Women

Recent Posts

  • Ukraine War: 272 Ghanaians & 1700 Africans Fighting For Russia – Kyiv Claims
  • Pedri & Ferran Torres: Barcelona Stars Reveal Flick’s Late Fine & Intermittent Fasting Diet
  • Crans-Montana Fire: New Video Reveals How Inferno Started
  • Infinix Note 60 Pro (2026): Specs, Price & Review
  • Robert Carradine: Smrt herce – sebevražda

Recent Comments

No comments to show.
Discover Hidden USA

Discover Hidden USA helps people discover hidden gems, local businesses, and services across the United States.

Quick Links

  • Privacy Policy
  • About Us
  • Contact
  • Cookie Policy
  • Disclaimer
  • Terms and Conditions

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

Connect With Us

© 2026 Discover Hidden USA. All rights reserved.

Privacy Policy Terms of Service